A documentary centred on Elizabeth Holmes — the Theranos founder currently incarcerated following her conviction — has drawn attention largely for its portrayal of her partner, Billy Evans, who holds power of attorney on her behalf and has taken on responsibility for overseeing her public profile during her imprisonment. A24 released You Can See Everything to cinema audiences, with the film now playing at theatres nationwide.

Nathan Fielder and Lance Oppenheim co-directed the project, with cameras rolling across 34 days that counted down to Holmes entering a minimum-security federal facility in Bryan, Texas, where she began serving her sentence in May 2023. The project grew out of an effort to understand Holmes's perspective, taking shape while she maintained her innocence after a jury convicted her in 2022 of defrauding investors in Theranos, the blood-testing company she had founded.

As the runtime stretches toward three hours, the documentary's attention gradually shifts until Evans himself stands at its centre. No details about the production were made public before the Telluride Film Festival named it among that year's world premieres.

Fielder — a comedian whose television work includes Nathan for You and The Rehearsal — was paired with Holmes in a combination that drew public attention as soon as it was announced. At a San Francisco gathering in the autumn of 2017, Evans — who holds a degree from MIT and was 34 at the time of writing — met Holmes for the first time.

Writing to the U.S. District Judge who handed down a sentence of more than 11 years against Holmes in November 2022, Evans noted that the Theranos founder had not been immediately recognisable to him, her appearance obscured by a sun hat and oversize glasses. That letter recounts how the pair found themselves drawn into an extended exchange, with Evans writing that romantic feelings took hold from the moment they met.

The bond between them held through the duration of Holmes's court proceedings. Roughly half a year after a criminal indictment was handed down against Holmes, the two travelled to Nevada's Black Rock Desert to attend Burning Man in 2018. A son was born to Holmes in the period leading up to her fraud trial.

Throughout the weeks the case played out in court, Evans was a regular presence at Holmes's side during arrivals and departures from the building. Relatives of Evans — whose family holds ownership of a hotel group based in San Diego — put forward written statements in support of Holmes. A second child joined the family in 2023.

In footage captured on camera, Evans discloses that he holds legal authority over Holmes through a power-of-attorney arrangement and manages her presence on X by posting there on her behalf. He also constructed an AI-generated avatar modelled on Holmes, with the stated aim of making it available for public interaction, though that avatar was never put before the public.

How far Holmes was aware of the decisions Evans was making on her behalf sits at the heart of what the documentary sets out to examine. Tight close-ups dominate the visual approach throughout the production, with Fielder and Oppenheim watching for signs that Holmes and Evans are steering how the documentary takes shape.

Footage captured during production shows both Evans and Holmes working together on plans to launch a medical testing venture — work that Evans continued to advance after Holmes entered prison. In footage reviewed as part of the production, Holmes can be seen telling Evans that sketches and concepts would be sent from behind bars. A person described as having direct knowledge of Evans's new project told reporters that Holmes is not involved in it.

When Fielder moved to question one of Evans's associates about Theranos, Evans intervened and brought that line of inquiry to a close. Questions over the money tied to the pair's involvement also sit at the heart of what the film sets out to examine.

According to Fielder's account, Evans held off on profit-sharing discussions until Holmes had stepped out of the room, at which point he secured a deal with A24 executives that entitled him to a share of the film's earnings. Footage in which Holmes states she is not being paid for her involvement in the project formed the basis of Fielder's concern that she had not been made aware of the request — a concern A24 ultimately accepted by agreeing to the terms.

A closing title card records that Evans chose not to pursue his compensation claim. At a post-screening conversation following the New York Film Festival debut, Fielder told the audience that Holmes had reached out to A24 on her own — driven by a wish to have her life documented — and that as production wound down, Evans had sought a degree of control over the project that left the team uncomfortable, with communication ultimately breaking down between the parties. Fielder characterised that outcome as running against the creative autonomy the filmmakers had considered essential to the work, while Oppenheim noted that the initial approach to A24 had come from Holmes herself.

Fielder noted that he and Oppenheim routinely arrived at different readings of the same moments they had both observed during filming — including several that made it into the final cut — with the two of them often walking away from a shared scene holding entirely opposing views about what it had meant or what had actually been taking place.

Days before the film's New York premiere, a post on Holmes's X account conveyed that those close to her had been helping manage her online presence, with the message noting that any future posts written directly by Holmes would carry the initials -EAH to distinguish them from content posted on her behalf. Posts published directly through Holmes's account carried the Theranos logo — a brand tied to the blood-testing company she had founded and led.

Journalism published across 2015 and 2016 documented that Theranos's technology fell short of the performance the company had advertised, that the organisation took steps to keep those shortcomings from public view, and that the wellbeing of patients was put at risk as a consequence. At the time, the company put out statements pushing back against those accounts.

A jury's guilty verdict on criminal fraud charges brought Holmes before a federal judge in late 2022, and the sentence handed down ran to more than 11 years — punishment tied to her role in deceiving the company's investors.